Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
暂无分享,去创建一个
[1] Afschin Gandjour,et al. Theoretical Foundation of Patient v. Population Preferences in Calculating QALYs , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[2] Stephen Joel Coons,et al. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.
[3] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[4] H. Jamaiyah,et al. The validation of the EQ-5D in Malaysian dialysis patients. , 2010, The Medical journal of Malaysia.
[5] O. Norheim,et al. Quantifying quality of life for economic analysis: time out for time trade off , 2003, Medical humanities.
[6] Paul Kind,et al. Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffs. , 2003, Health economics.
[7] Wan Ariffin Bin Abdullah,et al. Med J Malaysia , 2001 .
[8] Liang Li,et al. Some methodological issues with the analysis of preference-based EQ-5D index score , 2009, Health Services and Outcomes Research Methodology.
[9] P. Dolan,et al. The effect of past and present illness experience on the valuations of health states. , 1995, Medical care.
[10] D. Street,et al. International comparisons in valuing EQ-5D health states: a review and analysis. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] Nan Luo,et al. Validity, feasibility and acceptability of time trade-off and standard gamble assessments in health valuation studies: a study in a multiethnic Asian population in Singapore. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] M. Jo,et al. Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] Paul Kind,et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[14] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[15] Nancy Devlin,et al. Guidance to users of EQ-5D value sets , 2007 .
[16] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[17] Paul Kind,et al. How do Zimbabweans value health states? , 2003, Population health metrics.
[18] R. Willke,et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[19] N. Ikegami,et al. Estimating an EQ-5D population value set: the case of Japan. , 2002, Health economics.
[20] Milton C Weinstein,et al. Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.
[21] P. Dolan. Whose Preferences Count? , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[22] Nan Luo,et al. Valuations of EQ-5D Health States: Are the United States and United Kingdom Different? , 2005, Medical care.
[23] Mark Oppe,et al. EQ-5D value sets : inventory, comparative review, and user guide , 2007 .